CVS Health
CVS
2,308 hedge funds and large institutions have $95.2B invested in CVS Health in 2022 Q2 according to their latest regulatory filings, with 110 funds opening new positions, 954 increasing their positions, 981 reducing their positions, and 141 closing their positions.
31% more call options, than puts
Call options by funds: $1.36B | Put options by funds: $1.03B
20% more funds holding in top 10
Funds holding in top 10: 115 → 138 (+23)
0.01% more ownership
Funds ownership: 78.5% → 78.51% (+0.01%)
3% less repeat investments, than reductions
Existing positions increased: 954 | Existing positions reduced: 981
2% less funds holding
Funds holding: 2,366 → 2,308 (-58)
8% less capital invested
Capital invested by funds: $103B → $95.2B (-$8.3B)
22% less first-time investments, than exits
New positions opened: 110 | Existing positions closed: 141
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Morgan Stanley
New York
|
+$645M |
| 2 |
Nordea Investment Management
Stockholm,
Sweden
|
+$263M |
| 3 |
Vanguard Group
Malvern,
Pennsylvania
|
+$229M |
| 4 |
JP Morgan Chase
New York
|
+$207M |
| 5 |
AQR Capital Management
Greenwich,
Connecticut
|
+$195M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
VAM
Veritas Asset Management
London,
United Kingdom
|
-$600M |
| 2 |
DZ Bank
Frankfurt Am Main,
Germany
|
-$366M |
| 3 |
Harris Associates
Chicago,
Illinois
|
-$290M |
| 4 |
Janus Henderson Group
London,
United Kingdom
|
-$247M |
| 5 |
Capital International Investors
Los Angeles,
California
|
-$184M |
CVS Hedge Fund Activity: Q2 2022 in Review
2,308 of the 5,937 institutional investors tracked by Wall St. Rank reported a position in CVS Health (CVS) for Q2 2022, worth a combined $95.2B — down 8% from $103B a quarter earlier.
Sellers outnumbered buyers: 141 funds closed out of CVS and 110 opened new positions — a net loss of 31 holders — while 981 trimmed existing stakes and 954 added.
The largest buyer was Morgan Stanley, adding an estimated $645M. The largest seller was Veritas Asset Management, cutting an estimated $600M.
- 2,308 institutional investors held CVS Health (CVS) as of Q2 2022, down from 2,366 in Q1 2022.
- Funds reported $95.2B of CVS Health stock for Q2 2022, down 8% quarter-over-quarter.
- 110 funds opened new CVS Health positions in Q2 2022 and 141 closed out, a net change of -31 holders.
- The largest CVS Health buyer in Q2 2022 was Morgan Stanley, an estimated $645M added.
- The largest CVS Health seller in Q2 2022 was Veritas Asset Management, an estimated $600M sold.
Based on aggregated 13F filings for Q2 2022.